capmatinib 150 MG Oral Tablet [Tabrecta]

RxCUI: 2362240
RxNorm name: capmatinib 150 MG Oral Tablet [Tabrecta]
Display name: capmatinib 150 MG Oral Tablet [Tabrecta]
Full name: capmatinib 150 MG Oral Tablet [Tabrecta]
Term type: SBD
Status: DailyMed mapping
Updated: 2026-06-04 23:38:56

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
TABRECTA	CAPMATINIB	Novartis Pharmaceuticals Corporation	455892c3-d144-4ba8-9ab4-79cabff9876d	2025-12-15	Warnings, Adverse reactions	Exact identifier rxcui: 2362240

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
455892c3-d144-4ba8-9ab4-79cabff9876d	capmatinib 150 MG Oral Tablet [Tabrecta]	SBD	17	These highlights do not include all the information needed to use TABRECTA safely and effectively. See full prescribing information for TABRECTA. TABRECTA ® (capmatinib) tablets, for oral use Initial U.S. Approval: 2020	20251215
455892c3-d144-4ba8-9ab4-79cabff9876d	TABRECTA 150 MG Oral Tablet	PSN	17	These highlights do not include all the information needed to use TABRECTA safely and effectively. See full prescribing information for TABRECTA. TABRECTA ® (capmatinib) tablets, for oral use Initial U.S. Approval: 2020	20251215
455892c3-d144-4ba8-9ab4-79cabff9876d	Tabrecta 150 MG (as capmatinib HCl 176.55 MG) Oral Tablet	SY	17	These highlights do not include all the information needed to use TABRECTA safely and effectively. See full prescribing information for TABRECTA. TABRECTA ® (capmatinib) tablets, for oral use Initial U.S. Approval: 2020	20251215
455892c3-d144-4ba8-9ab4-79cabff9876d	Tabrecta 150 MG Oral Tablet	SY	17	These highlights do not include all the information needed to use TABRECTA safely and effectively. See full prescribing information for TABRECTA. TABRECTA ® (capmatinib) tablets, for oral use Initial U.S. Approval: 2020	20251215